Skip to main content
. Author manuscript; available in PMC: 2017 Jan 3.
Published in final edited form as: J Pediatr Oncol Nurs. 2014 May 5;31(4):191–199. doi: 10.1177/1043454214532024

Table 1. Hydration Evidence.

First Author, Year Study Design Subjects Findings GRADE quality level
Droller, 1982 Prospective, descriptive 198 adult patients with oncology or aplastic anemia diagnosis Significant HC prevalence difference between no hydration and IV fluids at 4-5 liters per day during CTX infusion (p< 0.01) High
Haselberger, 1995 Literature review Published evidence: high dose CTX in SCT Hydration/adequate urine flow should be mandatory with high dose CTX Moderate
Ballen, 1999 Prospective, descriptive 100 SCT adult patients Hydration with IV fluids at 250 ml/hr for 4 hours before through 24 hours after CTX effective in reducing HC Moderate
Takamoto, 2004 Case study 19 pediatric patients with solid tumor or hematological disease Acrolein concentrations increased as urine volume decreased; peak times were 1-12 hours after CTX Low

Abbreviations: SCT = stem cell transplant; IV = intravenous; CTX = Cytoxan; HC = hemorrhagic cystitis